Heart, Vascular & Thoracic Institute (Miller Family) Outcomes

Patients taking statins for primary cardiovascular disease prevention experienced reductions in low-density lipoprotein (LDL) cholesterol levels. Patients were seen at baseline, defined as their first visit, and had at least 2 follow-up visits within the past 2 years. The time between visits varied from patient to patient.

Patients taking statins for secondary cardiovascular disease prevention experienced reductions in low-density lipoprotein (LDL) cholesterol levels. Patients were seen at baseline, defined as their first visit, and had at least 2 follow-up visits within the past 2 years. The time between visits varied from patient to patient.